Skip to Content

ETH269 8 mg (Doxazosin Mesylate 8 mg)

Pill with imprint ETH269 8 mg is Blue, Elliptical / Oval and has been identified as Doxazosin Mesylate 8 mg. It is supplied by Ethex Corporation.

Doxazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; raynaud's syndrome and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Doxazosin 8 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ETH269 8 mg

Doxazosin Mesylate

Imprint:
ETH269 8 mg
Strength:
8 mg
Color:
Blue
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Ethex Corporation
Inactive Ingredients:
hydrated alumina
lactose monohydrate
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate
sodium starch glycolate
FD&C Blue No. 2 Aluminium Lake
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide